The largest database of trusted experimental protocols

Celltiter glo luminescent reagent

Manufactured by Promega
Sourced in United States

The CellTiter-Glo luminescent reagent is a laboratory assay kit used to determine the number of viable cells in a culture. The reagent quantifies the amount of adenosine triphosphate (ATP) present, which is a measure of metabolically active cells. The assay is based on the luciferase reaction, where the luminescence produced is proportional to the amount of ATP in the sample.

Automatically generated - may contain errors

30 protocols using celltiter glo luminescent reagent

1

CD44 Knockdown in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD44 gene is a well-known marker and shown to express in many cancers to play a significant role in the MS phenotype. To test the role of CD44 inhibition, we used gene specific siRNAs. For siRNA transfections, 2-pmol of either siCD44_1 (5′-CTGAAATTAGGGCCCAATTAA-3′, SI00012775) or siCD44_5 (5′-AACTCCATCTGTGCAGCAAAC -3′, S100299705) (Qiagen Inc., Germantown, MD) was complexed with RNAi Max lipid transfection reagent (Invitrogen) in DMEM media for 15 min at ambient temperature. Two thousand cells suspended in DMEM supplemented with 20% FBS were then added. Plates were maintained at ambient temperature for 15 min before being placed at 37 °C/5% CO2. Cell viability was assessed 24 and 48 h post siRNA transfection through quantification of ATP (CellTiter-Glo luminescent Reagent, Promega, Madison, WI). Untransfected cells and wells transfected with negative (All star siNegative [siNeg], Qiagen) and positive (All star siCelldeath, Qiagen) control siRNAs were used as controls. Protein for Western blot analysis was harvested 6 or 24 h post siRNA transfection.
+ Open protocol
+ Expand
2

siRNA Knockdown of MPS1 and miR-21

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described earlier (5) siRNA transfections, 2-pmol siMPS1, (5’ TTGGACTGTTATACTCTTGAA3’, SI00071624, si miR-21 (GeneSolution siRNA cat: 1027416 (mix of 4 validated anti Hs_miR-21)) (Qiagen Inc., Germantown, MD) was complexed with RNAi Max lipid transfection reagent (Invitrogen) in DMEM media for 15 minutes at ambient temperature. Two thousand cells suspended in DMEM supplemented with 20% FBS were then added. (For NMSP715 mediated inhibition of MPS1, cells were plated Overnight prior to drug treatment and treated with NMSP715 at the concentrations indicated in each experiment). Plates were maintained at ambient temperature for 15 minutes before being placed at 37 C/5% CO2. Cell viability was assessed five days post siRNA transfection through quantification of ATP (CellTiter-Glo luminescent Reagent, Promega, Madison, WI). Untransfected cells and wells transfected with negative (All-star siNegative [siNeg], Qiagen) and positive (All star siCelldeath, Qiagen) control siRNAs were used as controls. Proteins for Western blot analysis was harvested 48 hours post siRNA transfection or Drug treatments.
+ Open protocol
+ Expand
3

Cell Viability Assay for Various Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cervical cancer (HeLa, American Type Culture Collection (ATCC CCL-2), Manassas, VA, USA), neuroblastoma (SH-SY5Y, ATCC CRL-2266), and embryonic kidney (HEK293T, ATCC CRL-1573) cell lines were incubated in Dulbecco’s modified Eagle’s medium (DMEM) with 10% FBS and 1% antibiotics (penicillin-streptomycin, 10,000 U/mL) at 37 °C in a humidified atmosphere containing 5% CO2. Briefly, different (HeLa, SH-SY5Y, and HEK293) cell lines were cultured in 96-well plates with a density of 2 × 104 cells per well. After incubation for 24 h, the old medium was replaced with fresh medium containing different NP samples of various concentrations (100, 50, 25, 12.5, 6.5, 3.3, and 1.3 μg/mL). After another 48 h of incubation, the old medium was removed, followed by washing thrice with PBS, followed by the addition of 100 μL of fresh medium to each well. After incubation for 30 min, CellTiter-Glo Luminescent reagent (100 μL) (Promega, Madison, WI, USA) was added, followed by gentle shaking for 10 min at rt. The luminescence signal was measured using a microplate reader (Perkin Elmer, Victor X5, Waltham, MA, USA). The percentage cell viability was calculated based on the control (untreated) cells. The values were expressed as mean ± SD of triplicate experiments.
+ Open protocol
+ Expand
4

Siomycin A-Mediated FOXM1 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Siomycin A, an antibiotic thiazole compound (FOXM1 inhibitor) (cat no: sc-202339, Santa Cruz., USA) was reconstituted in dimethyl sulfoxide (DMSO) and stored at −20 C. Cells were plated overnight prior to drug treatment and treated at concentrations indicated in each experiment. Cell viability was assessed five days post drug treatment through quantification of ATP levels (CellTiter-Glo luminescent Reagent, Promega, Madison, WI). For siRNA mediated FOXM1 inhibition, 2-pmol siFOXM1 (FlexiTube GeneSolution GS2305 for FOXM1 (contains 4 validated siRNAs for FOXM1) (Qiagen Inc., Germantown, MD) was complexed with RNAi Max lipid transfection reagent (Invitrogen) in DMEM media for 15 minutes at room temperature. Cells suspended in DMEM supplemented with 20% FBS were then added. Plates were maintained at room temperature for 15 minutes before being placed at 37 C/5% CO2. Negative (All star siNegative [siNeg], Qiagen) and positive (All star siCelldeath, Qiagen) control siRNAs were used as controls. 48 hours post transfection cells were processed as indicated.
+ Open protocol
+ Expand
5

Bovine Corneal Endothelial Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bovine corneal endothelial cells were used in these experiments. At the end of incubation with drug and toxin (thapsigargin or H2O2), cell viability was determined by adding to each well 100 μL of CellTiter-Glo luminescent reagent (Promega, Madison, WI, USA), which produces light in direct proportion to the amount of ATP and viable cells present. Luminescence was measured in relative light units using a FLUO star OPTIMA luminometer (Optima, Tokyo, Japan). Drugs associated with increased luminescence (cell survival) compared with no drug-treated controls exposed to H2O2 and thapsigargin were selected for further study. Results were calculated as mean luminescence of treated replicates/mean luminescence of control replicates ×100. Control replicates were cultured in cell culture medium without H2O2, thapsigargin, or other additional agents. Level of cell protection for each agent (proportion of increased cell survival) against oxidative stress or UPR was assessed as grade 0 (no protection), less than 5%; grade 1 (low protection), 5% to 24%; grade 2 (medium protection), 25% to 44%; grade 3 (high protection), 45% to 69%; grade 4 (very high protection), 70% or more compared with cells with H2O2 or thapsigargin and no additional agent.11 (link)
+ Open protocol
+ Expand
6

High-Throughput Dose-Response Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the dose response curves, 1800 cells were plated in 36 μl per well of a 384 well plate on day one. Drugs were dissolved in DMSO and a 12 point, two-fold series was prepared. The drugs were then dissolved 1:33 in media and 4 μl was added to each well of the plates on day two. After 24-48 hours of drug treatment (based on the cell line), the viability of cells was measured using a 1:1 dilution of the CellTiter-Glo Luminescent reagent (Promega, cat# G7573) with media, which was read on a Victor 5 plate reader after 10 minutes shaking at room temperature. The intensity of luminescence was normalized to that of the DMSO control. Experiments were performed twice in duplicates each time.
For viability assays when the experiment was performed in 6-well plates, cells were harvested using trypsin (0.5 ml per well) and the media was saved from each well. The trypsinized cells were resuspended with the saved media and 2-3 aliquots (0.05 ml each) sampling different regions of this suspension were transferred into a 96-well plate to serve as technical replicates for the measurement. CellTiter-Glo Luminescent Viability assay was used to measure the viability of these aliquots. The rest of the cultures were used to extract protein to be analyzed using western blots.
+ Open protocol
+ Expand
7

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell viability, cell lines were plated at 2.5 × 104 cells per well in a 96-well plate and treated with SACLAC or DMSO vehicle (0.4% of total volume) for the indicated time points and doses. At the experiment end point, 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) Cell Proliferation Colorimetric Assay Kit (BioVision # K300–5000) reagent was added and incubated for 2 hours. Conversion of MTS to formazan product was measured by absorbance at 490 nm using a BioTek Cytation 3 plate reader. Absorbance was normalized to DMSO control, which was defined as 100% viability. Due to limited cell numbers, patient samples and normal samples were plated at 5×103 cells per well in a 384-well plate with SACLAC or DMSO control for the indicated time points and doses. At the experiment end point, CellTiter-Glo Luminescent reagent (Promega #G7572) was added. After 15 minutes, luminescence was read on a BioTek Cytation 3 plate reader. Absorbance was normalized to DMSO control, which was defined as 100% viability.
+ Open protocol
+ Expand
8

Luminescent Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CellTiter-Glo luminescent reagent (Promega, Madison, WI, U.S.A.) were used to determine cell viability according to the manufacturer's protocol.
+ Open protocol
+ Expand
9

Cell Death Quantification Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell death assays7 (link),9 (link),11 (link),42 (link), cells were trypsinized, collected and stained with trypan blue. The cells were counted with a hemocytometer using the standard protocol, and cells stained blue were considered as dead cells. The cell death was further confirmed by propidium iodide staining followed by FACS analysis. For CellTiter-Glo luminescent assay43 (link), 104 cells were plated 90 µL per well of a 96-well plate on day 1. The treatments were added to each well of the plates on day 2. The viability of cells was measured using 1:1 dilution of the CellTiter-Glo luminescent reagent (Promega G7572), which was read on a Glomax explorer (Promega) after 10 min of shaking at room temperature. The intensity of luminescence was normalized to that of DMSO control. Percentage of Cell death was counted as 100 minus percentage of cell viability.
+ Open protocol
+ Expand
10

Evaluating Synergistic Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured with an impedance-based instrument system (xCELLigence, Roche/ACEA Biosciences, Basel, Switzerland) enabling label-free real time cell analysis. Briefly, 2-4 × 104 cells were seeded into 96-wells with 200 μl culture media containing FBS and allowed to grow up to 150 h. Cellular impedance was measured periodically every 4 h (relative cell index) and HDACi, EEDi, chemotherapeutics or DMSO was added as indicated in the Results section.
For synergy evaluation 0.5-1 × 104 cells were seeded into white, flat-bottom, 96-well plates (Corning). Twenty-four hours later, doxorubicin and/or HDACi (FK228 or MS-275) were added, and viability was assessed after 72 h. Cell viability was measured using CellTiter-Glo Luminescent Reagent according to the manufacturer’s protocol (Promega). Luminescence was measured on a Promega GlowMax-Multi Detection System. Synergistic interactions were evaluated using the package Synergyfinder [30 (link)] (Package version 2.2.4, R version 4.0.3, RStudio version 1.3.1093) according to the Bliss algorithm [31 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!